Results for tag: "Dabigatran"

Dabigatran is a direct thrombin inhibitor used in the treatment of hematological diseases. It is used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). Dabigatran is a novel anticoagulant that has been approved for use in the United States, Europe, and other countries. It is a direct thrombin inhibitor, meaning it works by blocking the action of thrombin, a protein involved in the clotting process. The dabigatran market is highly competitive, with several companies offering products in the space. Some of the major players in the market include Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, and Sanofi. Other companies in the market include Daiichi Sankyo, Bayer, and GlaxoSmithKline. Show Less Read more